PaySign Inc. (PAYS)
NASDAQ: PAYS
· Real-Time Price · USD
3.85
0.52 (15.62%)
At close: May 15, 2025, 9:35 AM
PaySign Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|
| Other Revenue Revenue | 1.85M | 1.27M | 288.89K | 184.83K | 23.4M | 26.99M |
| Other Revenue Revenue Growth | +45.71% | +340.13% | +56.30% | -99.21% | -13.31% | n/a |
| Pharma Industry Revenue | 12.65M | n/a | n/a | n/a | n/a | n/a |
| Pharma Industry Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
| Plasma Industry Revenue | 43.88M | n/a | n/a | n/a | n/a | n/a |
| Plasma Industry Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 7.03M | 6.22M | 6.02M | 5.91M | 5.33M | 4.7M | 5.3M | 4.95M | 4.42M | 4.39M | 4.26M | 4.64M | 4M | 3.62M | 3.47M | 3.86M | 3.79M | 4.07M | 3.4M | 3.83M | 3.17M | 2.77M | 3.01M | 2.7M | 2.59M | 2M | 1.67M | 1.58M | 1.21M | 1.1M | 928.59K | 814.28K | 854.17K | 794.42K | 808.28K | 831.5K | 877.45K | 1.27M | 786.8K | 907.87K |
| Selling, General, and Administrative Revenue Growth | +13.08% | +3.28% | +1.85% | +10.90% | +13.49% | -11.46% | +7.26% | +11.96% | +0.69% | +3.07% | -8.29% | +16.15% | +10.44% | +4.13% | -10.10% | +1.91% | -6.83% | +19.66% | -11.13% | +20.63% | +14.71% | -8.20% | +11.39% | +4.42% | +29.72% | +19.73% | +5.63% | +30.73% | +9.38% | +18.92% | +14.04% | -4.67% | +7.52% | -1.71% | -2.79% | -5.24% | -30.95% | +61.51% | -13.34% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |